Skip to content

Exercise-snacks at Work: Impact on Cardiometabolic Parameters

Exercise-snacks: an Effective Strategy to Break Sitting Time and Improve Cardiometbaolic Health in Sedentary Overweight Office Workers

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05942144
Enrollment
23
Registered
2023-07-12
Start date
2023-05-16
Completion date
2024-07-20
Last updated
2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity, Sedentary Time, Work-Related Condition

Keywords

brief intense exercise, vascular function, cardiorespiratory fitness

Brief summary

The main objective is to measure the effects of intense brief exercise program in the workplace of administrative staff on the cardio-metabolic health

Detailed description

Backgrounds: Very short (\< 1 minute) and intense exercises, entitled exercise-snacks, have been reported to be effective 1) in improving physical fitness over 6 weeks and 2) in improving vascular function and lowering blood glucose levels over one day. These studies were all carried out in the laboratory. The question therefore arises as to whether these acute vascular and metabolic benefits, as well as those on physical fitness, are sustainable over time following a chronic exercise-snacks program applicable in the professional environment to sedentary, overweight people. Aims of this project is therefore to measure the effects of an exercise-snacks type physical activity program in the workplace of administrative staff on the cardio-metabolic health and sedentary behaviour of staff.

Interventions

OTHERExercise-snacks program

Subjects in the exercise-snacks group will perform 4 exercise-snacks sessions per working day for 4 weeks. These sessions will consist of 80 one-to-one walks to be completed as quickly as possible. They will also receive information about their attitudes to physical activity.

Sponsors

University of Avignon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* administrative staff, * age between 30 and 60, * body mass index ≥25kg/m², * sedentary time ≥7h/day, * minimum 3 working days on site, * no known cardiovascular or metabolic pathology, social security affiliation or benefit, * ability and willingness to give free, written and informed consent.

Exclusion criteria

* pregnant or breast-feeding women, * anti-hypertensive treatment, beta-blockers and anti-diabetics, * known contraindications to physical activity (articular, cardiac or other), * exercise-induced asthma, * lack of motivation of subjects posing problems of compliance and adherence to the exercise program, * participation in a study in the preceding 3 months, ongoing participation in a clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Changes in aerobic fitnessat inclusion, at the end of the 4-weeks program and 1 month following the end of the programAerobic fitness will be assessed via the Chester step test's prediction of VO2max

Secondary

MeasureTime frameDescription
Changes in fat massbetween the start and end of the 4-week exercise program and 4 weeks after the programmeasured by InBody, in kg
Adherence of staff in the experimental group by analyzing accelerometric data.during the 4-weeks programTotal number of exercise-snacks performed during the 4-week program by analysing accelerometers data
Intensity of exercise-snacksduring the 4-weeks programHeart rate during exercise-snacks in % heart rate max
Changes in flow mediated dilation of superficial femoral arteryat inclusion, at the end of the 4-weeks programmeasured by echocardiography (Vivid Q, GE) , in %
Changes in peak shear rate of superficial femoral arteryat inclusion, at the end of the 4-weeks programmeasured by echocardiography (Vivid Q, GE) during hyperemia, in s-1
Changes in nitrate mediated dilation of superficial femoral arteryat inclusion, at the end of the 4-weeks programby echocardiography (Vivid Q, GE), in %
Changes in superficial femoral artery complianceat inclusion, at the end of the 4-weeks programby echocardiography (Vivid Q, GE), in mm2 mmHg-1
Changes in carotid intima-thicknessat inclusion, at the end of the 4-weeks programby echocardiography (Vivid Q) in mm
Changes in level of habitual physical activitybetween the start and end of the 4-week exercise program and 4 weeks after the programPhysical Activity questionnaire
Changes in carotid-femoral pulse wave velocityat inclusion, at the end of the 4-weeks programby Sphygmocor, in m.s-1
Changes in post-occlusive skin perfusionat inclusion, at the end of the 4-weeks programby Laser Doppler (Perimed), in perfusion unit, in area under the curve, in time to peak
Changes in blood pressureat inclusion, at the end of the 4-weeks program and 1 month following the end of the programsystolic, diastolic, mean and pulsed
Changes in mean amplitude of glycemic excursionsone week before the beginning of the program and the first week of the program and the 2 lastest weeks of the programmeasured by continuous glucose monitoring (FreeStyle), in mmol.L-1
Changes in heart ratebetween the beginning and end of the 4-week exercise program and 4 weeks after the program.Heart rate at rest, at the end of the Chester step test and during exercise
Changes in lean massbetween the start and end of the 4-week exercise program and 4 weeks after the programmeasured by InBody, in kg
Change in physical activity behaviour at work of staffbetween the start and end of the 4-week exercise program.Theory of planned behavior questionnaire, score range from 20 to 80 with higher scores mean a better outcome.
Changes in rating of perceived exertionbetween the start and end of the 4-week exercise program and 4 weeks after the programmeasured during the Chester test, score range from 7 to 20 with higher scores mean a worse outcome.
Changes in carotid complianceat inclusion, at the end of the 4-weeks programby echocardiography (Vivid Q) in mm2 mmHg-1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026